Related references
Note: Only part of the references are listed.Enhanced Keap1-Nrf2 signaling protects the myocardium from isoproterenol-induced pathological remodeling in mice
Gobinath Shanmugam et al.
REDOX BIOLOGY (2019)
Upregulating Nrf2 in the RVLM ameliorates sympatho-excitation in mice with chronic heart failure
Anyun Ma et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Curcumin improves exercise performance of mice with coronary artery ligation-induced HFrEF: Nrf2 and antioxidant mechanisms in skeletal muscle
Ahmed M. Wafi et al.
JOURNAL OF APPLIED PHYSIOLOGY (2019)
Therapeutic targeting of the NRF2 and KEAP 1 partnership in chronic diseases
Antonio Cuadrado et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Myocardial infarction-induced microRNA-enriched exosomes contribute to cardiac Nrf2 dysregulation in chronic heart failure
Changhai Tian et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2018)
Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt/GSK-3ss/Fyn pathway
Ying Xin et al.
REDOX BIOLOGY (2018)
Recent novel approaches to limit oxidative stress and inflammation in diabetic complications
Raelene J. Pickering et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2018)
The NRF2 activator DH404 attenuates adverse ventricular remodeling postmyocardial infarction by modifying redox signalling
Kristen J. Bubb et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Selective Nrf2 Gene Deletion in the Rostral Ventrolateral Medulla Evokes Hypertension and Sympathoexcitation in Mice
Lie Gao et al.
HYPERTENSION (2017)
The Role of Nrf2 in Cardiovascular Function and Disease
Sandro Satta et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Antioxidant Therapeutic Strategies for Cardiovascular Conditions Associated with Oxidative Stress
Jorge G. Farias et al.
NUTRIENTS (2017)
Sulforaphane protection against the development of doxorubicin-induced chronic heart failure is associated with Nrf2 Upregulation
Yang Bai et al.
CARDIOVASCULAR THERAPEUTICS (2017)
Bardoxolone methyl prevents the development and progression of cardiac and renal pathophysiologies in mice fed a high-fat diet
Danielle Camer et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
Statins and oxidative stress in chronic heart failure
Sonia Costa et al.
REVISTA PORTUGUESA DE CARDIOLOGIA (2016)
Novel Targets of Drug Treatment for Pulmonary Hypertension
Jian Hu et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2015)
Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease
Lauren E. Tebay et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Sulforaphane Protects against Cardiovascular Disease via Nrf2 Activation
Yang Bai et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
A Newly Designed Curcumin Analog Y20 Mitigates Cardiac Injury via Anti-Inflammatory and Anti-Oxidant Actions in Obese Rats
Yuanyuan Qian et al.
PLOS ONE (2015)
Mechanisms Contributing to Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl
Melanie P. Chin et al.
AMERICAN JOURNAL OF NEPHROLOGY (2014)
Left Ventricular End-Diastolic Pressure Predicts Survival in Coronary Artery Bypass Graft Surgery Patients
Jeevan Nagendran et al.
ANNALS OF THORACIC SURGERY (2014)
Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl
Melanie P. Chin et al.
JOURNAL OF CARDIAC FAILURE (2014)
The Nrf2 pathway in the progression of renal disease
Carlamaria Zoja et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Role of Nrf2 in Oxidative Stress and Toxicity
Qiang Ma
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)
Up-down Regulation of HO-1 and iNOS Gene Expressions by Ethyl Pyruvate via Recruiting p300 to Nrf2 and Depriving It from p65
Seung-Woo Kim et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease
Stacey Ruiz et al.
KIDNEY INTERNATIONAL (2013)
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
Dick de Zeeuw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection
Meijuan Zhang et al.
PROGRESS IN NEUROBIOLOGY (2013)
Fumarate Is Cardioprotective via Activation of the Nrf2 Antioxidant Pathway
Houman Ashrafian et al.
CELL METABOLISM (2012)
Role of Oxidative Stress in Disease Progression in Stage B, a Pre-cursor of Heart Failure
Arvind Bhimaraj et al.
HEART FAILURE CLINICS (2012)
Diabetic Downregulation of Nrf2 Activity via ERK Contributes to Oxidative Stress-Induced Insulin Resistance in Cardiac Cells In Vitro and In Vivo
Yi Tan et al.
DIABETES (2011)
Redox signaling in cardiac myocytes
Celio X. C. Santos et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Oxidation of Myofibrillar Proteins in Human Heart Failure
Marcella Canton et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
Pablo E. Pergola et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Proteomic Analysis Shows Synthetic Oleanane Triterpenoid Binds to mTOR
Mark M. Yore et al.
PLOS ONE (2011)
Exercise training prevents the exaggerated exercise pressor reflex in rats with chronic heart failure
Han-Jun Wang et al.
JOURNAL OF APPLIED PHYSIOLOGY (2010)
Nrf2 Protects Against Maladaptive Cardiac Responses to Hemodynamic Stress
Jinqing Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis
Wenge Li et al.
BIOCHEMICAL PHARMACOLOGY (2008)
NF-κB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK
Guang-Hui Liu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2008)
Extracellular superoxide dismutase deficiency exacerbates pressure overload-induced left ventricular hypertrophy and dysfunction
Zhongbing Lu et al.
HYPERTENSION (2008)
The synthetic triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole blocks nuclear factor-κB activation through direct inhibition of IκB kinase β
Mark M. Yore et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Free radicals, mitochondria, and oxidized lipids - The emerging role in signal transduction in vascular cells
Jessica Gutierrez et al.
CIRCULATION RESEARCH (2006)
The synthetic triterpenoid CDDO-imidazolide suppresses STAT phosphorylation and induces apoptosis in myeloma and lung cancer cells
Karen Liby et al.
CLINICAL CANCER RESEARCH (2006)
Mitochondrial oxidative stress, DNA damage, and heart failure
Hiroyuki Tsutsui et al.
ANTIOXIDANTS & REDOX SIGNALING (2006)
Augmented input from cardiac sympathetic afferents inhibits baroreflex in rats with heart failure
L Gao et al.
HYPERTENSION (2005)
Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents:: Role of antioxidant response element-like sequences in the nrf2 promoter
MK Kwak et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts
DA Siwik et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2001)
Share Paper
